Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 34 checked references that resolve
resolves10.3310/hta7010How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
resolves10.1016/j.mehy.2005.08.026A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
resolves10.1159/000357743Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience
resolves10.1111/j.1468-1331.2010.03328.xA randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex<sup>®</sup>), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
resolves10.1191/026921599677595404A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity
resolves10.1016/j.brs.2009.03.001Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans
resolves10.1016/0013-4694(94)90029-9Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee
resolves10.1016/j.clinph.2003.12.025The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse
resolves10.1007/s40265-014-0197-5Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis
resolves10.1159/000360285Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice
resolves10.1016/j.clinph.2003.11.024Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation
resolves10.1007/s00415-009-5047-0Intracortical excitability in patients with relapsing–remitting and secondary progressive multiple sclerosis
resolves10.1038/346561a0Structure of a cannabinoid receptor and functional expression of the cloned cDNA
resolves10.1177/135245859600200503Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study
resolves10.1038/35003583Cannabinoids control spasticity and tremor in a multiple sclerosis model
resolves10.1007/s10072-009-0136-5Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis
resolves10.1016/j.brs.2012.02.001Short interval intracortical facilitation correlates with the degree of disability in multiple sclerosis
resolves10.1002/mds.10627One‐Hz repetitive transcranial magnetic stimulation of the premotor cortex alters reciprocal inhibition in DYT1 dystonia
checked 2026-07-22 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.